Kawasaki, Japan

Kunihiro Hirai


 

Average Co-Inventor Count = 3.8

ph-index = 2

Forward Citations = 30(Granted Patents)


Location History:

  • Kanagawa, JP (2015)
  • Kawasaki, JP (2014 - 2021)

Company Filing History:


Years Active: 2014-2025

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Kunihiro Hirai: Innovator in Oligonucleotide Production

Introduction

Kunihiro Hirai is a prominent inventor based in Kawasaki, Japan. He has made significant contributions to the field of oligonucleotide production, holding a total of 6 patents. His innovative methods have advanced the efficiency and purity of oligonucleotide synthesis.

Latest Patents

Hirai's latest patents include a production method for oligonucleotides. This method involves removing a temporary protecting group of a 5'-hydroxyl group by adding an acid to a protected oligonucleotide. The process also includes deacylating a by-product with an acylated 5′-hydroxyl group through solvolysis, which enhances the condensation yield while significantly reducing impurities such as single base deletion forms. Another notable patent describes a process for producing oligonucleotides by condensing nucleosides, nucleotides, or oligonucleotides in a non-polar solvent, followed by oxidation or sulfurization to yield a protected oligonucleotide. The final steps involve deprotecting and purifying the oligonucleotide, ensuring high-quality results.

Career Highlights

Kunihiro Hirai is currently employed at Ajinomoto Co., Ltd., where he continues to innovate in the field of biochemistry. His work has not only contributed to the scientific community but has also had practical applications in various industries, including pharmaceuticals and biotechnology.

Collaborations

Hirai has collaborated with notable colleagues such as Satoshi Katayama and Daisuke Takahashi. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in their respective fields.

Conclusion

Kunihiro Hirai's contributions to oligonucleotide production exemplify the impact of innovative thinking in science and technology. His patents reflect a commitment to improving methodologies that benefit both research and industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…